Corcept Therapeutics
CORT
#2082
Rank
S$11.83 B
Marketcap
S$112.29
Share price
1.89%
Change (1 day)
42.36%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): S$86 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.74 Billion. In 2024 the company made an earning of S$0.17 Billion, an increase over its 2023 earnings that were of S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$86 M-51.39%
2024 S$0.17 B27.66%
2023 S$0.13 B-4.75%
2022 S$0.14 B-9.51%
2021 S$0.16 B-2.91%
2020 S$0.16 B14.87%
2019 S$0.14 B24.71%
2018 S$0.11 B69.32%
2017 S$68.28 M419.26%
2016 S$13.14 M-395.64%
2015 -S$4.45 Million-87.53%
2014 -S$35.69 Million-33.44%
2013 -S$53.61 Million
2011 -S$41.77 Million17.84%
2010 -S$35.45 Million35.5%
2009 -S$26.16 Million2.84%
2008 -S$25.44 Million60.81%
2007 -S$15.82 Million-52.14%
2006 -S$33.05 Million20.91%
2005 -S$27.34 Million31.87%
2004 -S$20.73 Million60.54%
2003 -S$12.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.85 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.37 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.21 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$29.07 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.31 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.82 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.45 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$39.76 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA